Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer's disease
- PMID: 20061648
- PMCID: PMC2905865
- DOI: 10.3233/JAD-2010-1254
Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer's disease
Abstract
The major barrier to treating or preventing Alzheimer's disease (AD) is its unknown etiology and pathogenesis. Although increasing evidence supports a role for mitochondrial dysfunction in the pathogenesis of AD, there have been few studies that simultaneously evaluate changes in multiple mitochondrial proteins. To evaluate changes in sites of potentially interacting mitochondrial proteins, we applied 2-dimensional liquid chromatography coupled with tandem mass spectrometry and the isotope coded affinity tag method to identify and quantify proteins in mitochondrial enriched fractions isolated from short postmortem interval temporal pole specimens from subjects with mild cognitive impairment (4 subjects pooled), early AD (4 subjects pooled), late-stage AD (8 subjects pooled) and age-matched normal control (7 subjects pooled) subjects. A total of 112 unique, non-redundant proteins were identified and quantified in common to all three stages of disease progression. Overall, patterns of protein change suggest activation of mitochondrial pathways that include proteins responsible for transport and utilization of ATP. These proteins include adenine nucleotide translocase, voltage dependent anion channels, hexokinase, and creatine kinase. Comparison of protein changes throughout the progression of AD suggests the most pronounced changes occur in early AD mitochondria.
Figures








Similar articles
-
The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression.J Neurosci Res. 2010 Dec;88(16):3566-77. doi: 10.1002/jnr.22528. Epub 2010 Oct 8. J Neurosci Res. 2010. PMID: 20936705
-
Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.J Proteomics. 2011 Apr 1;74(4):466-79. doi: 10.1016/j.jprot.2010.12.012. Epub 2011 Jan 13. J Proteomics. 2011. PMID: 21237293
-
Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.Mol Neurobiol. 2018 Oct;55(10):7839-7857. doi: 10.1007/s12035-018-0955-6. Epub 2018 Feb 22. Mol Neurobiol. 2018. PMID: 29468564
-
Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.Prog Neurobiol. 2013 Jul-Aug;106-107:33-54. doi: 10.1016/j.pneurobio.2013.06.002. Epub 2013 Jul 1. Prog Neurobiol. 2013. PMID: 23827971 Review.
-
Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Acta Neuropathol. 2009 Jul;118(1):131-50. doi: 10.1007/s00401-009-0517-0. Epub 2009 Mar 14. Acta Neuropathol. 2009. PMID: 19288120 Free PMC article. Review.
Cited by
-
Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?Mol Cell Proteomics. 2016 Feb;15(2):409-25. doi: 10.1074/mcp.R115.053330. Epub 2015 Dec 11. Mol Cell Proteomics. 2016. PMID: 26657538 Free PMC article. Review.
-
Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease.Proteomics Clin Appl. 2012 Apr;6(3-4):201-11. doi: 10.1002/prca.201100068. Proteomics Clin Appl. 2012. PMID: 22532456 Free PMC article.
-
Oral administration of D-galactose increases brain tricarboxylic acid cycle enzymes activities in Wistar rats.Metab Brain Dis. 2021 Jun;36(5):1057-1067. doi: 10.1007/s11011-021-00682-y. Epub 2021 Feb 22. Metab Brain Dis. 2021. PMID: 33616841
-
Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.Expert Rev Proteomics. 2016;13(3):259-74. doi: 10.1586/14789450.2016.1149470. Expert Rev Proteomics. 2016. PMID: 26837425 Free PMC article. Review.
-
Copper metabolism-related Genes in entorhinal cortex for Alzheimer's disease.Sci Rep. 2023 Oct 14;13(1):17458. doi: 10.1038/s41598-023-44656-9. Sci Rep. 2023. PMID: 37838728 Free PMC article.
References
-
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–1122. - PubMed
-
- Swerdlow RH, Kish SJ. Mitochondria in Alzheimer's disease. Int Rev Neurobiol. 2002;53:341–385. - PubMed
-
- Jost BC, Grossberg GT. The natural history of Alzheimer's disease: a brain bank study. J Am Geriatr Soc. 1995;43:1248–1255. - PubMed
-
- Regula KM, Ens K, Kirshenbaum LA. Mitochondria-assisted cell suicide: a license to kill. J. Molecular and Cellular Cardiology. 2003;35:559–567. - PubMed
-
- Pollack M, Leeuwaenburgh Apoptosis and aging: Role of the mitochondria. J. Gerontology. 2001;56A:B475–B482. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical